Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 31

Trial Status

Completed10
Recruiting1
Terminated1

Role Distribution

Principal Investigator10
Other Roles2
PI Rate83%

Activity Timeline

Clinical Trials (12)

NCT05237258Not ApplicableRecruiting
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
High Risk Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaRelapsed Adult AML
PrincipalinvestigatorStart date: 2022-06-01
NCT03375489Not ApplicableCompleted
Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer
Lung Cancer
PrincipalinvestigatorStart date: 2018-06-15
NCT03337399Not ApplicableCompleted
Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
Lung Cancer
PrincipalinvestigatorStart date: 2018-02-01
NCT02069769Not ApplicableCompleted
Ensuring Communication in Hospice by Oncology Study (ECHO)
Cervical CancerHead and Neck CancerMelanoma+3 more
PrincipalinvestigatorStart date: 2014-01-01
NCT00622193Phase 2Completed
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Studydirector
NCT01401894Completed
Perception Prognosis, Goals of Treatment, and Communication
Biliary CancerEsophageal CancerGastric Cancer+2 more
Principalinvestigator

Showing 10 of 12 trials

Research Network

Collaboration Network

9 collaborators·23 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Areej El-Jawahri, MD

Massachusetts General Hospital

Moderately Similar
21 trials

Shared therapeutic areas:

High Risk Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaRelapsed Adult AML

Worked with same sponsors:

Massachusetts General HospitalNational Cancer Institute (NCI)+1 more
Collaborated on 1 trial
Similarity Score34%

Serena Mraz, MD

Solano Clinical Research

Related
1 trials

Shared therapeutic areas:

EGFR Inhibitor-associated Rash

Worked with same sponsors:

Spectrum Pharmaceuticals, Inc
Collaborated on 1 trial
Similarity Score14%

Cliff Perlis, MD

Fox Chase Cancer Center, Rockledge, PA

Related
1 trials

Shared therapeutic areas:

EGFR Inhibitor-associated Rash

Worked with same sponsors:

Spectrum Pharmaceuticals, Inc
Collaborated on 1 trial
Similarity Score14%

Vera Hirsh, MD

McGill University

Related
1 trials

Shared therapeutic areas:

EGFR Inhibitor-associated Rash

Worked with same sponsors:

Spectrum Pharmaceuticals, Inc
Collaborated on 1 trial
Similarity Score14%

Maria Colavincenzo, MD

Robert H. Lurie Cancer Center, Northwestern University

Related
1 trials

Shared therapeutic areas:

EGFR Inhibitor-associated Rash

Worked with same sponsors:

Spectrum Pharmaceuticals, Inc
Collaborated on 1 trial
Similarity Score14%

Milan Anadkat, MD

Washington University School of Medicine

Related
1 trials

Shared therapeutic areas:

EGFR Inhibitor-associated Rash

Worked with same sponsors:

Spectrum Pharmaceuticals, Inc
Collaborated on 1 trial
Similarity Score14%

Madeline Duvic, MD

MD Anderson Cancer Center, Houston, TX

Related
1 trials

Shared therapeutic areas:

EGFR Inhibitor-associated Rash

Worked with same sponsors:

Spectrum Pharmaceuticals, Inc
Collaborated on 1 trial
Similarity Score14%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverLung CancerCancer of Pancreas+8 more
Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaCarcinoma, Non-Small-Cell LungOvary Cancer+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Cancer of EsophagusLung CancerCancer of Stomach+2 more

Worked with same sponsors:

Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT05237258Not ApplicablePrincipalInvestigator

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

High Risk Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaRelapsed Adult AML
Recruiting
NCT03375489Not ApplicablePrincipalInvestigator

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Lung Cancer
Completed
NCT03337399Not ApplicablePrincipalInvestigator

Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer

Lung Cancer
Completed
NCT03220100Not ApplicablePrincipalInvestigator

Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOL

Lung Cancer
Terminated
NCT02349412Phase 3StudyChair

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Anxiety DisorderDepressionEsophageal Cancer+7 more
Completed
NCT02069769Not ApplicablePrincipalInvestigator

Ensuring Communication in Hospice by Oncology Study (ECHO)

Cervical CancerHead and Neck CancerMelanoma+3 more
Completed
NCT00656786Phase 1PrincipalInvestigator

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

EGFR Inhibitor-associated Rash
Completed
NCT00622193Phase 2StudyDirector

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
Completed
NCT01038271Not ApplicablePrincipalInvestigator

Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer
Completed
NCT01401894PrincipalInvestigator

Perception Prognosis, Goals of Treatment, and Communication

Biliary CancerEsophageal CancerGastric Cancer+2 more
Completed
NCT01401907Not ApplicablePrincipalInvestigator

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies

Esophageal CancerGastric CancerLiver Cancer+4 more
Completed
NCT02730858Not ApplicablePrincipalInvestigator

Palliative and Oncology Care Model in Breast Cancer

Metastatic Breast Cancer
Completed

All 12 trials loaded